1
|
Gogoll C, Peters EMJ, Köllner V, Koczulla AR. S1 Leitlinie Long-/Post-COVID Syndrom. Pflege Z 2023; 76:30-33. [PMID: 37216183 PMCID: PMC10188219 DOI: 10.1007/s41906-023-2076-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Je nach Virusvariante sind ca. 5 % der COVID-19-Erkrankten in unterschiedlicher Schwere vom Post-COVID-Syndrom (PCS) betroffen. Insbesondere werden krankhafte Erschöpfung, pulmonale und neurokognitive Störungen bis hin zu Angstzuständen und Depressionen gefunden. Für die Entstehung des PCS ist es unerheblich, ob der akute Verlauf der Erkrankung asymptomatisch, mild oder schwer war. Die Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) hat ihr erstes Update der S1-Leitlinie zum Long-/Post-COVID-Syndrom veröffentlicht. Auch die dazugehörige Patientenleitlinie, die unter Beteiligung der Betroffenenorganisationen entstanden ist, ist aktualisiert worden.
Collapse
Affiliation(s)
- Christian Gogoll
- Ev. Lungenklinik Berlin, Schönstr. 5-7, 13086 Berlin, Deutschland
| | - Eva M J Peters
- Ev. Lungenklinik Berlin, Schönstr. 5-7, 13086 Berlin, Deutschland
| | - Volker Köllner
- Ev. Lungenklinik Berlin, Schönstr. 5-7, 13086 Berlin, Deutschland
| | | |
Collapse
|
2
|
Schwarzkopf D, Rüddel H, Brinkmann A, Fleischmann-Struzek C, Friedrich ME, Glas M, Gogoll C, Gründling M, Meybohm P, Pletz MW, Schreiber T, Thomas-Rüddel DO, Reinhart K. The German Quality Network Sepsis: Evaluation of a Quality Collaborative on Decreasing Sepsis-Related Mortality in a Controlled Interrupted Time Series Analysis. Front Med (Lausanne) 2022; 9:882340. [PMID: 35573007 PMCID: PMC9094049 DOI: 10.3389/fmed.2022.882340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Accepted: 03/31/2022] [Indexed: 11/13/2022] Open
Abstract
Background Sepsis is one of the leading causes of preventable deaths in hospitals. This study presents the evaluation of a quality collaborative, which aimed to decrease sepsis-related hospital mortality. Methods The German Quality Network Sepsis (GQNS) offers quality reporting based on claims data, peer reviews, and support for establishing continuous quality management and staff education. This study evaluates the effects of participating in the GQNS during the intervention period (April 2016–June 2018) in comparison to a retrospective baseline (January 2014–March 2016). The primary outcome was all-cause risk-adjusted hospital mortality among cases with sepsis. Sepsis was identified by International Classification of Diseases (ICD) codes in claims data. A controlled time series analysis was conducted to analyze changes from the baseline to the intervention period comparing GQNS hospitals with the population of all German hospitals assessed via the national diagnosis-related groups (DRGs)-statistics. Tests were conducted using piecewise hierarchical models. Implementation processes and barriers were assessed by surveys of local leaders of quality improvement teams. Results Seventy-four hospitals participated, of which 17 were university hospitals and 18 were tertiary care facilities. Observed mortality was 43.5% during baseline period and 42.7% during intervention period. Interrupted time-series analyses did not show effects on course or level of risk-adjusted mortality of cases with sepsis compared to the national DRG-statistics after the beginning of the intervention period (p = 0.632 and p = 0.512, respectively). There was no significant mortality decrease in the subgroups of patients with septic shock or ventilation >24 h or predefined subgroups of hospitals. A standardized survey among 49 local quality improvement leaders in autumn of 2018 revealed that most hospitals did not succeed in implementing a continuous quality management program or relevant measures to improve early recognition and treatment of sepsis. Barriers perceived most commonly were lack of time (77.6%), staff shortage (59.2%), and lack of participation of relevant departments (38.8%). Conclusion As long as hospital-wide sepsis quality improvement efforts will not become a high priority for the hospital leadership by assuring adequate resources and involvement of all pertinent stakeholders, voluntary initiatives to improve the quality of sepsis care will remain prone to failure.
Collapse
Affiliation(s)
- Daniel Schwarzkopf
- Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.,Department for Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.,Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
| | - Hendrik Rüddel
- Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.,Department for Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany
| | - Alexander Brinkmann
- Department of Anesthesiology and Intensive Care Medicine, General Hospital of Heidenheim, Heidenheim, Germany
| | - Carolin Fleischmann-Struzek
- Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.,Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
| | | | - Michael Glas
- Department for Infectious Diseases and Infection Control, KH Labor GmbH, AMEOS Group, Bernburg, Germany
| | - Christian Gogoll
- Outpatient Services, Evangelische Lungenklinik Berlin-Buch, Berlin, Germany
| | - Matthias Gründling
- Department of Anesthesiology, University Hospital of Greifswald, Greifswald, Germany
| | - Patrick Meybohm
- Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Germany
| | - Mathias W Pletz
- Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
| | - Torsten Schreiber
- Department of Anesthesia and Intensive Care, Zentralklinik Bad Berka, Bad Berka, Germany
| | | | - Konrad Reinhart
- Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.,Berlin Institute of Health, Campus Virchow-Klinikum, Berlin, Germany.,Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| |
Collapse
|
3
|
Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick R. [S1 Guideline "Post-COVID/Long-COVID"]. Chirurg 2022. [PMID: 35041036 DOI: 10.1007/s00104-021-01543-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- A R Koczulla
- LL-Sekretariat Anja Flender, Schön Klinik Berchtesgadener Land, Malterhöh 1, 83471, Schönau am Königssee, Deutschland.
| | - T Ankermann
- Gesellschaft für Pädiatrische Pneumologie (DGPP), Berlin, Deutschland
| | - U Behrends
- Chronisches Fatigue Centrum, Klinikum rechts der Isar der Technischen Universität München, München, Deutschland
| | - P Berlit
- Deutsche Gesellschaft f. Neurologie (DGN), Berlin, Deutschland
| | - S Böing
- Berufsverband der Pneumologen (BdP), Heidenheim, Deutschland
| | - F Brinkmann
- Gesellschaft für Pädiatrische Pneumologie (DGPP), Berlin, Deutschland
| | - C Franke
- Berufsverband der Pneumologen (BdP), Heidenheim, Deutschland
| | - R Glöckl
- Deutsche Gesellschaft f. Pneumologie und Beatmungsmedizin (DGP), Berlin, Deutschland
| | - C Gogoll
- Deutsche Gesellschaft f. Pneumologie und Beatmungsmedizin (DGP), Berlin, Deutschland
| | - T Hummel
- Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn, Deutschland
| | - J Kronsbein
- Deutsche gesetzliche Unfallversicherung (DGUV), Berlin, Deutschland
| | - T Maibaum
- Deutsche Gesellschaft f. Neurologie (DGN), Berlin, Deutschland
| | - E M J Peters
- Deutsche Gesellschaft f. Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM), Stuttgart, Deutschland
| | - M Pfeifer
- Deutsche Gesellschaft f. Pneumologie und Beatmungsmedizin (DGP), Berlin, Deutschland
| | - T Platz
- Deutsche Gesellschaft für Neurorehabilitation (DGNR), Rheinbach, Deutschland
| | - M Pletz
- Sektion Infektiologie, Paul Ehrlich Gesellschaft für Chemotherapie e.V. (PEG), Köln, Deutschland
| | - G Pongratz
- Deutsche Schmerzgesellschaft der Deutschen Migräne und Kopfschmerzgesellschaft, Königstein im Taunus, Deutschland.,Deutsche Gesellschaft für Rheumatologie, Berlin, Deutschland
| | - F Powitz
- Berufsverband der Pneumologen (BdP), Heidenheim, Deutschland
| | - K F Rabe
- Deutsche Gesellschaft f. Pneumologie und Beatmungsmedizin (DGP), Berlin, Deutschland
| | | | - A Stallmach
- Deutsche Gesellschaft f. Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS), Berlin, Deutschland.,Deutsche Gesellschaft f. Infektiologie (DGI), Berlin, Deutschland
| | - M Stegbauer
- Deutsche gesetzliche Unfallversicherung (DGUV), Berlin, Deutschland
| | - H O Wagner
- Deutsche Gesellschaft f. Allgemeinmedizin und Familienmedizin (DEGAM), Berlin, Deutschland
| | - C Waller
- Deutsches Kollegium für Psychosomatische Medizin (DKPM), Berlin, Deutschland
| | - H Wirtz
- Deutsche Gesellschaft f. Pneumologie und Beatmungsmedizin (DGP), Berlin, Deutschland
| | - A Zeiher
- Deutsche Gesellschaft f. Kardiologie - Herz- und Kreislaufforschung (DGK), Düsseldorf, Deutschland
| | - R Zwick
- Österreichische Gesellschaft für Pneumologie (ÖGP), Wien, Österreich
| |
Collapse
|
4
|
Gogoll C, Leo F, Schueller PO, Grohé C. [Post-COVID sequela of the lung - follow up and treatment]. Dtsch Med Wochenschr 2021; 146:e113. [PMID: 34706377 DOI: 10.1055/a-1676-8223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Gogoll C, Leo F, Schueller PO, Grohé C. [Post-COVID sequela of the lung - follow up and treatment]. Dtsch Med Wochenschr 2021; 146:1399-1404. [PMID: 34670282 DOI: 10.1055/a-1492-8808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Most people recover completely after an acute infection with the novel corona virus SARS-CoV2. But some people continue to experience symptoms after their recovery. This phenomenon is called post-acute or long-COVID (from week 4 after the infection up to week 12) and persistent post-COVID (symptoms for effects that persist 12 or more weeks after onset). The exact processes that cause long COVID remain unknown.Most of those patients suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise. Today, 18 months after the first infections in Europe we have access to the first practical guidelines for the long-/post-COVID syndrome. Further on first prospective studies analysing the incidence of post-COVID are now available.In this review we will discuss some questions about treatment and follow up of patients suffering from pulmonary sequelae after their COVID-19 infection, based on the actual literature.
Collapse
|
6
|
Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH. [S1 Guideline Post-COVID/Long-COVID]. Pneumologie 2021; 75:869-900. [PMID: 34474488 DOI: 10.1055/a-1551-9734] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The German Society of Pneumology initiated the AWMFS1 guideline Post-COVID/Long-COVID. In a broad interdisciplinary approach, this S1 guideline was designed based on the current state of knowledge.The clinical recommendation describes current post-COVID/long-COVID symptoms, diagnostic approaches, and therapies.In addition to the general and consensus introduction, a subject-specific approach was taken to summarize the current state of knowledge.The guideline has an expilcit practical claim and will be continuously developed and adapted by the author team based on the current increase in knowledge.
Collapse
Affiliation(s)
| | | | - Uta Behrends
- Klinikum rechts der Isar der Technischen Universität München, Chronisches Fatigue Centrum
| | | | | | | | | | - Rainer Glöckl
- Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
| | - Christian Gogoll
- Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
| | - Thomas Hummel
- Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V
| | | | - Thomas Maibaum
- Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)
| | - Eva M J Peters
- Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)
| | - Michael Pfeifer
- Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
| | - Thomas Platz
- Deutsche Gesellschaft für Neurorehabilitation (DGNR) und Redaktionskomitee S2k-LL SARS-CoV-2, COVID-19 und (Früh-) Rehabilitation
| | - Matthias Pletz
- Paul Ehrlich Gesellschaft für Chemotherapie e. V. (PEG)/Sektion Infektiologie
| | - Georg Pongratz
- Deutsche Schmerzgesellschaft, Deutsche Migräne- und Kopfschmerzgesellschaft und Deutsche Gesellschaft für Rheumatologie
| | | | - Klaus F Rabe
- Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
| | | | - Andreas Stallmach
- Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS), Deutsche Gesellschaft für Infektiologie (DGI)
| | | | - Hans Otto Wagner
- Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)
| | | | - Hubert Wirtz
- Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
| | - Andreas Zeiher
- Deutsche Gesellschaft für Kardiologie- Herz- und Kreislaufforschung (DGK)
| | | |
Collapse
|
7
|
Martinelli M, Gogoll C. RB-ILD nach Methamphetaminhydrochlorid-Inhalation bei Erstmanifestation einer systemischer Sklerose. Pneumologie 2016. [DOI: 10.1055/s-0036-1572165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Martinelli M, Gogoll C, Derwahl M. Ventil-Dislokation nach endoskopischer Volumenreduktion. Pneumologie 2016. [DOI: 10.1055/s-0036-1572215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Martinelli M, Mauch H, Rüssmann H, Roth A, Schönfeld N, Bauer TT, Derwahl M, Gogoll C. Isoliert Moxifloxacin-resistente Tuberkulose – ein Fallbericht. Pneumologie 2015. [DOI: 10.1055/s-0035-1544806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
10
|
Gogoll C, Gravemann S, Derwahl K. Propofol mit sog. Nurse-administered propofol sedation (NAPS) versus Midazolam. Pneumologie 2011. [DOI: 10.1055/s-0031-1271996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Gogoll C, Gravemann S, Derwahl K. Eine seltene Ursache für einen Pleuraerguss. Pneumologie 2011. [DOI: 10.1055/s-0031-1272077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Gogoll C, Derwahl K. Nächtliche Beatmung von Diabetikern mit schlafbezogener Atemstörung. Pneumologie 2011. [DOI: 10.1055/s-0031-1272127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Gogoll C, Jürgens V, Giesche K, Derwahl KM. Screening auf das Vorliegen einer schlafbezogenen Atemstörungen im Rahmen der Diagnostik beim metabolischen Syndrom. Pneumologie 2008. [DOI: 10.1055/s-2008-1074229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
14
|
Gogoll C, Derwahl K, Naoum C, Dietel M, Frei U. Gastrointestinale Blutung als seltene Manifestation eines M. Wegener. Pneumologie 2007. [DOI: 10.1055/s-2007-973347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|